tiprankstipranks
Tianjin Pharmaceutical Adjusts A-Share Repurchase Strategy
Company Announcements

Tianjin Pharmaceutical Adjusts A-Share Repurchase Strategy

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.

Don't Miss Our Christmas Offers:

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. has adjusted the repurchase price for its Restricted A-Shares under the 2019 Incentive Scheme, following a board meeting. They plan to repurchase and cancel 63,920 Restricted A-Shares due to performance assessments, affecting a small fraction of their total share capital. This move could influence the company’s stock dynamics and investor interest.

For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Singapore Auto-Generated NewsdeskTianjin Pharmaceutical Completes Major Capital Injection
TipRanks Singapore Auto-Generated NewsdeskTianjin Pharmaceutical Releases Restricted A-Shares
TipRanks Singapore Auto-Generated NewsdeskTianjin Pharmaceutical Holds Global Shareholder Meeting
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App